DESCRIBE <http://purl.uniprot.org/SHA-384/0CDA6152346360F073A658E4C1AE2A95B5229D302FF1B7DBE54F6996C5F6A524F097171683A63AEB55BF2671AF93279D>

Subject	Predicate	Object
http://purl.uniprot.org/SHA-384/0CDA6152346360F073A658E4C1AE2A95B5229D302FF1B7DBE54F6996C5F6A524F097171683A63AEB55BF2671AF93279D	http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/0CDA6152346360F073A658E4C1AE2A95B5229D302FF1B7DBE54F6996C5F6A524F097171683A63AEB55BF2671AF93279D	http://www.w3.org/2000/01/rdf-schema#comment	"Data show that cyclin-dependent kinase 5 (CDK5) siRNA inhibits epithelial-to-mesenchymal transition (EMT) via extracellular signal-regulated kinase 1/2 (ERK1/2)/peroxisome proliferator-activated receptor gamma (PPRAgamma) pathway in high glucose cultured renal tubular cell line NRK-52E cells."xsd:string
http://purl.uniprot.org/uniprot/#_AAD49ACDC24DFFCEB5D21DC6DFA5C9646D47648DEF576354747F9A44CFEB21A6C8481955C34E3D6B9FD9BA02237D3772	http://www.w3.org/1999/02/22-rdf-syntax-ns#subject	http://purl.uniprot.org/SHA-384/0CDA6152346360F073A658E4C1AE2A95B5229D302FF1B7DBE54F6996C5F6A524F097171683A63AEB55BF2671AF93279D
http://purl.uniprot.org/uniprot/O88275	http://purl.uniprot.org/core/mappedAnnotation	http://purl.uniprot.org/SHA-384/0CDA6152346360F073A658E4C1AE2A95B5229D302FF1B7DBE54F6996C5F6A524F097171683A63AEB55BF2671AF93279D
http://purl.uniprot.org/uniprot/#_O88275-mappedCitation-27145370	http://purl.uniprot.org/core/mappedAnnotation	http://purl.uniprot.org/SHA-384/0CDA6152346360F073A658E4C1AE2A95B5229D302FF1B7DBE54F6996C5F6A524F097171683A63AEB55BF2671AF93279D